Opus Genetics Inc
Opus Genetics Inc (IRD) Implied Volatility Current
IRD implied volatility is 92%. IV Rank is 6%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking IRD implied volatility helps you identify when options premiums on Opus Genetics Inc are historically cheap or expensive, and where the best trades are hiding. Opus Genetics Inc implied volatility reflects the market's expectation of future price movement: when IRD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Opus Genetics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IRD, tracking metrics like IRD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IRD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy.
The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IRD implied volatility sits today versus where it has been. Our scanner ranks Opus Genetics Inc implied volatility against its historical range, surfaces extremes in IRD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Opus Genetics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 16, 2026
Trade options with IV on your side
Track IRD IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→